Get the Stockscreener App
1.02
3.03%
0.03
Fractyl Health Inc stock is traded at $1.02, with a volume of 1.38M.
It is up +3.03% in the last 24 hours and down -45.16% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$0.99
Open:
$0.9869
24h Volume:
1.38M
Relative Volume:
1.83
Market Cap:
$51.29M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-0.6543
EPS:
-1.559
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-45.16%
6M Performance:
-28.17%
1Y Performance:
-64.95%
1-Day Range:
$0.97
$1.055
1-Week Range:
$0.9501
$1.06
52-Week Range:
$0.825
$3.72
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.02 | 71.59M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-24 | Initiated | Evercore ISI | Outperform |
| Feb-27-24 | Initiated | BofA Securities | Buy |
| Feb-27-24 | Initiated | Morgan Stanley | Overweight |
Fractyl Health Inc Stock (GUTS) Latest News
Fractyl Health price target lowered to $6 from $12 at Canaccord - MSN
Fractyl Health Inc. Ranks High in Smart Money Tracker2025 Big Picture & Growth Focused Investment Plans - kangso.co.kr
Fractyl Health shares rise 1.98% premarket after Pareto Brokers internal trade of approximately 0.5 percent. - AInvest
Fractyl Health, Inc. shares rise 1.47% intraday as Stockholm Stock Exchange dips 0.58% ahead of White House summit. - AInvest
Fractyl Health announces proposed public offering - MSN
Fractyl Health Inc. Shows Support at Fibonacci LevelBull Run & Stock Portfolio Risk Management - metal.it
Fractyl Health Reports Q2 2025 Financial Results and Progress - MSN
Analyzing drawdowns of Fractyl Health Inc. with statistical toolsFed Meeting & High Accuracy Swing Entry Alerts - Newser
Live market analysis of Fractyl Health Inc.2025 Trading Recap & Stock Portfolio Risk Control - Newser
What candlestick patterns are forming on Fractyl Health Inc.July 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
Fractyl Health shares rise 2.05% after-hours following HydroGraph's collaboration with Hawkeye Bio for lung cancer screening. - AInvest
Canaccord Genuity lowers Fractyl Health stock price target to $6 from $12 - Investing.com India
Fractyl Health First Half 2025 Earnings: US$1.06 loss per share (vs US$0.57 loss in 1H 2024) - Yahoo Finance
Can machine learning forecast Fractyl Health Inc. recoveryQuarterly Profit Summary & Reliable Intraday Trade Alerts - Newser
Price action breakdown for Fractyl Health Inc.Weekly Profit Analysis & AI Enhanced Trading Alerts - Newser
What’s the profit margin of Fractyl Health Inc.July 2025 Big Picture & AI Forecasted Entry and Exit Points - thegnnews.com
Fractyl Health outlines upcoming REMAIN-1 and Rejuva milestones while strengthening cash position - MSN
Chart overlay techniques for tracking Fractyl Health Inc.Trade Risk Summary & Short-Term High Return Ideas - Newser
Fractyl Health Posts 62% Wider Q2 Loss - AOL.com
Fractyl Health Inc (GUTS) Q2 2025 Earnings Call Highlights: Financial Discipline and Promising ... By GuruFocus - Investing.com Canada
Fractyl Health (GUTS) and the Post-GLP-1 Weight Maintenance Opportunity: A Clinical and Commercial Breakthrough in Metabolic Disease - AInvest
Fractyl Health's Strategic Positioning in the Post-GLP-1 Market: A Catalyst-Driven Opportunity for 2025–2026 - AInvest
Fractyl Health's 2025 Q2 Earnings Call: Unpacking Key Contradictions in IND Clearance, Weight Management, and Market Strategy - AInvest
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Earnings call transcript: Fractyl Health Q2 2025 sees increased R&D, net loss - Investing.com Australia
Fractyl Health Advances Post-GLP-1 Weight Maintenance Treatment as September Trial Results Near - Stock Titan
Fractyl Health Q2 2025 Earnings Call Transcript - MarketBeat
Short Interest Drops in Fractyl Health Inc. After RallyBreakout Confirmation With Entry Tracker Enabled - beatles.ru
Bollinger Bands Expand on Fractyl Health Inc. — Volatility AheadShort Term Setup With Predictive Chart Confirmed - beatles.ru
Is Fractyl Health Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Stock Selection With High Accuracy - Newser
Market reaction to Fractyl Health Inc.’s recent newsNext Day Momentum Stock Forecasting Report - Newser
Biotech Alert: Searches spiking for these stocks today - TipRanks
Fractyl Health shares rise 1.75% intraday after closing $23 million public offering. - AInvest
Fractyl Health raises $23 million in public offering with warrants By Investing.com - Investing.com Canada
Fractyl Health raises $23 million in public offering with warrants - Investing.com India
Fractyl Health Announces Closing of $23 Million - GlobeNewswire
Fractyl Health Raises $23M in Public Offering, Could Expand to $69M Through Warrants - Stock Titan
Bank of New York Mellon Corp Increases Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference - The Manila Times
Fractyl Health to Report Second Quarter 2025 Financial - GlobeNewswire
Fractyl Health prices 19.05M shares at $1.05 in underwritten public offering - TipRanks
Fractyl Health's GUTS Plummets 47%: What's Fueling the Sudden Freefall? - AInvest
Fractyl Health stock plunges after $20 million public offering - Investing.com India
Fractyl Health stock plunges after $20 million public offering By Investing.com - Investing.com Australia
Fractyl Health (GUTS.O) Plummets 49%: Technical Signals, Order-Flow Clues, and Sector Divergence Point to Key Catalyst - AInvest
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Benzinga
Fractyl Health prices $20 million public offering of common stock - Investing.com
Fractyl Health prices $20 million public offering of common stock By Investing.com - Investing.com South Africa
Fractyl Health announces pricing of $20 million underwritten public offering - MarketScreener
Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering - GlobeNewswire
Fractyl Health Secures $20M Funding to Advance Revolutionary Diabetes and Obesity Therapeutics - Stock Titan
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fractyl Health Inc Stock (GUTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Barnes Kelly Ann | Director |
Mar 14 '25 |
Buy |
1.30 |
31,000 |
40,210 |
31,000 |
| SCHULMAN AMY W | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| BRADLEY WILLIAM | Director |
Mar 13 '25 |
Buy |
1.26 |
16,129 |
20,358 |
16,129 |
| Conaway Samuel | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Option Exercise |
1.70 |
90,972 |
154,652 |
582,301 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):